The combination of TAS-102 and bevacizumab as the third-line chemotherapy for metastatic colorectal cancer (TAS-CC3 Study).

被引：0
|
作者：
Kosugi, Chihiro
Kamiyama, Hirohiko
Yoshida, Yoichiro
Yoshida, Hiroshi
Ishibashi, Keiichiro
Ihara, Keisuke
Takahashi, Makoto
Kuramochi, Hidekazu
Sonoda, Hiromichi
Yoshimatsu, Kazuhiko
Fukazawa, Atsuko
Matsuda, Akihisa
Yamaguchi, Satoru
Ishida, Hideyuki
Hasegawa, Suguru
Yamada, Takeshi
Narushima, Kazuo
Shuto, Kiyohiko
Sakamoto, Kazuhiro
Koda, Keiji
机构：
[1] Teikyo Univ, Chiba Med Ctr, Ichihara, Chiba, Japan
[2] Juntendo Univ, Sch Med, Dept Coloproctol Surg, Bunkyo Ku, Tokyo, Japan
[3] Fukuoka Univ, Fukuoka, Fukuoka, Japan
[4] Nippon Med Univ, Dept Gastroenterol Surg, Tokyo, Japan
[5] Saitama Med Univ, Saitama, Japan
[6] Dokkyo Univ, Dept Surg Oncol, Sch Med, Mibu, Tochigi, Japan
[7] 3-1-3 Hongo,Bunkyo Ku, Tokyo, Japan
[8] Tokyo Womens Med Univ, Yachiyo Med Ctr, Yachiyoshi Chiba, Japan
[9] Shiga Univ Med Sci, Dept Surg, Otsu, Shiga, Japan
[10] Saiseikai Kurihashi Hosp, Dept Surg, Kuki, Saitama, Japan
[11] Iwata City Hosp, Dept Surg, Iwata, Shizuoka, Japan
[12] Chiba Hokusoh Hosp, Nippon Med Sch, Dept Surg, Chiba, Japan
[13] Fukuoka Univ, Sch Med, Dept Gastroenterol Surg, Fukuoka, Fukuoka, Japan
[14] Nippon Med Sch, Dept Digest Surg, Tokyo, Japan
[15] Teikyo Univ, Chiba Med Ctr, Ichihara, Chiba, Japan
[16] Juntendo Univ, Sch Med, Dept Coloproctol Surg, Tokyo, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 04期
关键词：
D O I：
10.1200/JCO.2019.37.4_suppl.614
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
614
引用
收藏
页数：2
相关论文
共 50 条
  • [21] TAS-102 for the treatment of metastatic colorectal cancer
    Salvatore, Lisa
    Rossini, Daniele
    Moretto, Roberto
    Cremolini, Chiara
    Schirripa, Marta
    Antoniotti, Carlotta
    Marmorino, Federica
    Loupakis, Fotios
    Falcone, Alfredo
    Masi, Gianluca
    EXPERT REVIEW OF ANTICANCER THERAPY, 2015, 15 (11) : 1283 - 1292
  • [22] TAS-102 for metastatic refractory colorectal cancer
    Cleghorn, Sean
    LANCET ONCOLOGY, 2015, 16 (07): : E314 - E314
  • [23] A Comparison of Bevacizumab Plus TAS-102 and TAS-102 Monotherapy for Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis
    Chen, Xiaochen
    Qiu, Huafeng
    Chen, Yunwang
    Wang, Mingxing
    Zhu, Pengfei
    Pan, Shuangyue
    Deng, Yaya
    Yang, Liu
    Chen, Zheling
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [24] Bevacizumab in Combination with TAS-102 Improves Clinical Outcomes in Patients with Refractory Metastatic Colorectal Cancer: A Retrospective Study
    Fujii, Hironori
    Matsuhashi, Nobuhisa
    Kitahora, Mika
    Takahashi, Takao
    Hirose, Chiemi
    Iihara, Hirotoshi
    Yamada, Yunami
    Watanabe, Daichi
    Ishihara, Takuma
    Suzuki, Akio
    Yoshida, Kazuhiro
    ONCOLOGIST, 2020, 25 (03): : E469 - E476
  • [25] TAS-102 plus bevacizumah with metastatic colorectal cancer in salvage line
    Osawa, Hiroshi
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2018, 42 : S23 - S23
  • [26] Anlotinib combined with TAS-102 as the third-line treatment for a patient with metastatic colon cancer: A case report
    Li, Qizheng
    Zhang, Xia
    Fan, Buqun
    Yang, Yudie
    Cui, Xiaonan
    Zhang, Jie
    Jiang, Kaiteng
    Zhang, Chunxia
    Zhang, Bin
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [27] Treatment of TAS-102 in patients with metastatic colorectal cancer
    Ota, Takayo
    Tsukuda, Hiroshi
    Hasegawa, Yoshikazu
    Miyatake, Nozomi
    Suzumura, Tomohiro
    Fukuoka, Masahiro
    ANNALS OF ONCOLOGY, 2016, 27
  • [28] Comparative efficacy of TAS-102 and chemotherapy rechallenge in the third-line setting and beyond in patients with advanced colorectal cancer: A retrospective study.
    Alanazi, Rakan
    Alotaibi, Khalid
    Ali, Murtada Mohamed
    Abushara, Ahmed
    Albahrani, Zainab
    Alsehali, Afrah
    Almesfir, Reem
    Alsubaie, Razan
    Alkaiyat, Mohammad
    Shehata, Husam
    Sabatin, Fouad
    Algarni, Mohammed Ahmed
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 78 - 78
  • [29] Retrospective analysis of TAS-102 for metastatic colorectal cancer
    Aoki, M.
    Shimamoto, F.
    Ikegami, T.
    Yamaguchi, T.
    Terazawa, T.
    Kii, T.
    Goto, M.
    Higuchi, K.
    ANNALS OF ONCOLOGY, 2017, 28
  • [30] A novel antimetabolite: TAS-102 for metastatic colorectal cancer
    Miyamoto, Yuji
    Lenz, Heinz-Josef
    Baba, Hideo
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2016, 9 (03) : 355 - 365
12345